Western Blotting Market Booming with New Opportunities

The report "Western Blotting Market by Product, (Consumables (Antibody), Instrument (Electrophoresis, Blotting System, Imager (Fluorescent))), Application (Biomedical, Clinical Diagnostics), End User (Research Institute, Hospital, Biopharma) - Global Forecast to 2026", The global western blotting market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period. Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors driving the market growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=235810711&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Western blotting is a widely used technique in the field of biotechnology and molecular biology. It is used to detect, quantify and analyze proteins in a sample. Western blotting is used to detect the presence of a specific protein in a sample and to determine its relative abundance.

The rising demand for early diagnosis and the increasing prevalence of infectious diseases are the major factors driving the growth of the market.

Furthermore, the development of advanced products and the increasing emphasis on personalized medicine are also expected to drive the growth of the market. The increasing investment in research and development activities, the availability of government funding, and the growing focus on drug discovery are some of the other factors expected to drive the market's growth.

The increasing demand for point-of-care testing and the rising investment in research and development activities are some of the key trends observed in the market. Moreover, the increasing demand for automated western blotting instruments and the introduction of novel techniques such as immunoassays and ELISAs are also expected to drive the growth of the market.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=235810711&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Key Market Players

Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Techne Corporation (US), and Merck KGaA (Germany) are the prominent players operating in the western blotting market.

BIO-RAD LABORATORIES, INC. (US)

Bio-Rad Laboratories is a leading player in the western blotting market in 2020. The company is a leading manufacturer and supplier of products and systems to separate, detect, analyze, and purify complex biological and chemical materials. The company's leading position in the market can be attributed to its wide customer base. Bio-Rad, with its ~8,000 employees (as of 2020), serves a wide and diversified customer base that includes universities and research institutes, supporting about 150,000 scientists in the US; companies operating in the pharmaceutical, biotechnology, chemical, and food industries; diagnostic manufacturers; and commercial laboratories and hospitals.

The company is also equipped with a strong distribution channel. Bio-Rad has established an extensive direct sales force and service network of approximately 740 sales and service representatives in more than 35 countries to conduct its worldwide operations efficiently. With its experienced industry experts, the company maintains a separate sales force for each of its segments. In addition, the company's agents and distributors also assist in sales, especially in the international markets. The direct sales approach permits Bio-Rad to establish direct contact with its customers, thus helping the company to build strong relationships with customers.

THERMO FISHER SCIENTIFIC INC. (US)

Thermo Fisher Scientific held the second position in the western blotting market in 2020. The company provides a wide range of products in this market, including protein gels, protein standards & ladders, protein electrophoresis buffers & reagents, protein gel electrophoresis chamber systems, power supplies for protein electrophoresis, and protein gel staining and imaging products. These products are made available through Thermo Fisher Scientific's broad sales force and global network of resellers and distributors. In recent years, organic strategies such as new product launches have enabled the company to maintain its position in the western blotting market. For Instance, in June 2019, the company launched a new imaging series-Invitrogen iBright 1500. The iBright 1500 series is designed to support a broad set of applications. It can be used to image fluorescent western blots, chemiluminescent western blots, colorimetric blots, and stained protein and nucleic acid gels.

The Asia Pacific region is the fastest-growing region of the western blotting market

the Asia Pacific region accounted for the fast growing region of the western blotting market. . The major factors driving the growth of the Asia Pacific market include strong government support for the growth of the pharmaceutical and biotechnology industry, the presence of bio clusters in China and India, increasing funding for life science research, and growing initiatives related to target disease diagnosis.

Recent Developments

• In September 2021, PerkinElmer, Inc. (US) acquired BioLegend (US), a leading provider of life science antibodies and reagents, including primary antibodies and western blot secondary reagents. This acquisition enhances the company's existing western blotting product portfolio.

• In August 2021, Abcam Plc (UK) acquired BioVision Inc. (US), a global supplier of life science research tools for research, diagnostics, and drug discovery. The company is a leading provider of biochemical and cell-based assays and produces a wide portfolio of other products, including recombinant proteins, antibodies, enzymes, and biochemical compounds for immunoassay technologies such as western blotting

• In April 2021, Bio-Techne Corporation (US) launched Abby, a next-generation chemiluminescence system that automates traditional western blotting

Buy Complete Western Blotting Report @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=235810711&utm_source=OPenpr&utm_campaign=Paid&utm_content=Referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.